|NIH Human Embryonic Stem Cell Registry|
|Research Using This Line is Eligible for NIH Funding|
Detailed information for selected cell line:
|NIH Registration Number:||0083|
|NIH Approval Number:||NIHhESC-10-0083|
|Available for Distribution:||Yes|
For research purposes only; no therapeutic use in humans. Use as per Government of India Guidelines for Stem Cell Research and Therapy.
|NIH Restrictions:||(No Additional Restrictions)|
The owners of the cell lines are- Jawaharlal Nehru Centre for Advanced Scientific Research, Bangalore; National Centre for Biological Sciences, Bangalore and Bangalore Assisted Conception Centre, Bangalore.
The cell lines are available from the originator upon approval by a Steering Committee and signing of an MTA. The two cell lines have been deposited in the UK Stem Cell Bank and are due for release soon. Please see http://www.ukstemcellbank.org.uk/catalogue.html The cell lines are also listed in the hESC Registry, Europe.
Please see publication- Derivation and characterization of two sibling human embryonic stem cell lines from discarded Grade III embryos. Inamdar et al., Stem Cells and Development., 2009 Apr;18(3):423-33. The cells are in continuous culture for over 30 months (more than passage no. 200) and maintain pluripotent phenotype.
|Submitting Organization:||Jawaharlal Nehru Centre for Advanced Scientific Research|
|Provider Name:||Jawaharlal Nehru Centre for Advanced Scientific Research|
(Emails that are offensive or unrelated to stem cells will be deleted.)